Abstract:Background Prognostic assessment is important for the management of patients with acute pulmonary embolism (APE). Pulmonary Embolism Severity Index (PESI) and simple PESI (sPESI) are new emerged prognostic assessment tools for APE. The aim of this meta-analysis is to assess the accuracy of the PESI and the sPESI to predict prognostic outcomes (all-cause and PE-related mortality, serious adverse events) in APE patients, and compare between these two PESIs. Methods MEDLINE and EMBASE database were searched up to June 2012 using the terms “Pulmonary Embolism Severity Index” and “pulmonary embolism”. Summary odds ratio (OR) with 95% confidence intervals (CIs) for prognostic outcomes in low risk PESI versus high risk PESI were calculated. Summary receiver operating characteristic curve (SROC) used to estimate overall predicting accuracies of prognostic outcomes. Results Twenty-one studies were included in this meta-analysis. The results showed low-risk PESI was significantly associated with lower all-cause mortality (OR 0.13; 95% CI 0.12 to 0.15), PE-related mortality (OR 0.09; 95% CI 0.05 to 0.17) and serious adverse events (OR 0.34; 95% CI 0.29 to 0.41), with no homogeneity across studies. In sPESI subgroup, the OR of all-cause mortality, PE-related mortality, and serious adverse events was 0.10 (95% CI 0.08 to 0.14), 0.09 (95% CI 0.03 to 0.26) and 0.40 (95% CI 0.31 to 0.51), respectively; while in PESI subgroup, the OR was 0.14 (95% CI 0.13 to 0.16), 0.09 (95% CI 0.04 to 0.21), and 0.30 (95% CI 0.23 to 0.38), respectively. For accuracy analysis, the pooled sensitivity, the pooled specificity, and the overall weighted AUC for PESI predicting all-cause mortality was 0.909 (95% CI: 0.900 to 0.916), 0.411 (95% CI: 0.407 to 0.415), and 0.7853±0.0058, respectively; for PE-related mortality, it was 0.953 (95% CI: 0.913 to 0.978), 0.374 (95% CI: 0.360 to 0.388), and 0.8218±0.0349, respectively; for serious adverse events, it was 0.821 (95% CI: 0.795 to 0.845), 0.389 (95% CI: 0.384 to 0.394), and 0.6809±0.0208, respectively. In sPESI subgroup, the AUC for predicting all-cause mortality, PE-related mortality, and serious adverse events was 0.7920±0.0117, 0.8317±0.0547, and 0.6454±0.0197, respectively. In PESI subgroup, the AUC was 0.7856±0.0075, 0.8158±0.0451, and 0.6609±0.0252, respectively. Conclusions PESI has discriminative power to predict the short-term death and adverse outcome events in patients with acute pulmonary embolism, the PESI and the sPESI have similar accuracy, while sPESI is easier to use. However, the calibration for predicting prognosis can’t be calculated from this meta-analysis, some prospective studies for accessing PESI predicting calibration can be recommended.

A Radiological Nomogram to Predict 30-day Mortality in Patients with Acute Pulmonary Embolism

Development and Validation of a Radiomics Nomogram for Diagnosis of Malignant Pleural Effusion.

A prognostic prediction model for acute pulmonary embolism

Short‐term mortality prediction in acute pulmonary embolism: Radiomics values of skeletal muscle and intramuscular adipose tissue

A Dynamic Nomogram for Predicting 28-Day Mortality in Septic Shock: a Chinese Retrospective Cohort Study

A novel prognostic prediction indicator in patients with acute pulmonary embolism: Naples prognostic score

Performance of the Simplified Pulmonary Embolism Severity Index in Predicting 30-Day Mortality after Acute Pulmonary Embolism: Validation from a Large-Scale Cohort.

A nomogram predicting 30-day mortality in patients undergoing percutaneous coronary intervention

PERFORM: Pulmonary Embolism Risk Score for Mortality in Computed Tomographic Pulmonary Angiography-Confirmed Patients

Utilization of a Novel Scoring System in Predicting 30-day Mortality in Acute Pulmonary Embolism, the CLOT-5 Pilot Study

Computed tomography-based radiomics model to predict adverse clinical outcomes in acute pulmonary embolism

[A Comparison of the Predictive Values of Three Clinical Scoring Systems for Suspected Acute Pulmonary Embolism Based on Multidetector CT Angiography].

Development and validation of a predictive model for 30-day mortality in patients with severe community-acquired pneumonia in intensive care units

Prognostic value of pulmonary artery diameter/aorta diameter ratio in patients with acute pulmonary embolism

A nomogram for predicting mortality risk within 30 days in sepsis patients admitted in the emergency department: A retrospective analysis

Prediction of mortality in acute pulmonary embolism in cancer-associated thrombosis (MAUPE-C): derivation and validation of a multivariable model

Imaging and Biomarkers: The Assesment of Pulmonary Embolism Risk and Early Mortality

Saddle Pulmonary Embolism: Laboratory and Computed Tomographic Pulmonary Angiographic Findings to Predict Short-term Mortality

Construction of Prediction Model Integrating the Radiomics Features of Segmented Clots for Risk Stratification in Acute Pulmonary Embolism

The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis

Interpretable Machine Learning Approach for Predicting 30-Day Mortality of Critical Ill Patients with Pulmonary Embolism and Heart Failure: A Retrospective Study